Ditchcarbon
  • Contact
  1. Organizations
  2. Boehringer Ingelheim (Canada) Ltd./Ltée.
Public Profile
Research Pending

This profile hasn't yet passed our validation checks

Submit your email to push it up the queue

We'll prioritize this organization's research and notify you when detailed sustainability data becomes available.

Pharmaceutical Preparation Manufacturing
CA
updated 7 months ago

Boehringer Ingelheim (Canada) Ltd./Ltée.

Company website

Boehringer Ingelheim (Canada) Ltd./Ltée., a subsidiary of the global pharmaceutical giant Boehringer Ingelheim, is headquartered in Canada and operates extensively across the country. Founded in 1885, the company has established itself as a leader in the pharmaceutical industry, focusing on human pharmaceuticals, animal health, and biopharmaceutical contract manufacturing. With a commitment to innovation, Boehringer Ingelheim offers a diverse range of core products and services, including prescription medications and vaccines that address critical health challenges. The company is renowned for its research-driven approach, which has led to significant advancements in therapeutic areas such as respiratory diseases, oncology, and diabetes care. Boehringer Ingelheim's strong market position is underscored by its dedication to improving patient outcomes and its notable achievements in developing unique therapies that enhance quality of life. As a trusted name in healthcare, the company continues to make impactful contributions to both human and animal health sectors.

DitchCarbon Score

How does Boehringer Ingelheim (Canada) Ltd./Ltée.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

32

Industry Benchmark

Boehringer Ingelheim (Canada) Ltd./Ltée.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.

32%

Let us know if this data was useful to you

Boehringer Ingelheim (Canada) Ltd./Ltée.'s reported carbon emissions

Boehringer Ingelheim (Canada) Ltd./Ltée. currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Boehringer Ingelheim, which may influence its climate commitments and strategies. As of now, there are no documented reduction targets or climate pledges from Boehringer Ingelheim (Canada) Ltd./Ltée. This lack of specific initiatives suggests that the company may be in the early stages of developing its climate action framework or may rely on broader corporate strategies from its parent organisation. Given the absence of direct emissions data and reduction initiatives, it is essential to monitor future disclosures from Boehringer Ingelheim (Canada) Ltd./Ltée. for updates on their carbon emissions and climate commitments.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Boehringer Ingelheim (Canada) Ltd./Ltée.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Boehringer Ingelheim (Canada) Ltd./Ltée. is in CA, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Boehringer Ingelheim (Canada) Ltd./Ltée. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Glaxosmithkline

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 19 hours ago

Sandoz Canada Inc.

CA
•
Pharmaceutical Preparation Manufacturing
Updated 24 days ago

MERCK Kommanditgesellschaft auf Aktien

DE
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Csl

AU
•
Pharmaceutical Preparation Manufacturing
Updated 24 minutes ago

Daiichi Sankyo

JP
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251008.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy